Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 218

Results For "US"

8096 News Found

PM Modi launches Ayushman Bharat Digital Mission
Public Health | September 27, 2021

PM Modi launches Ayushman Bharat Digital Mission

The Mission will simplify hospital processes and will increase Ease of Living. Under this, every citizen will get a digital health ID and their health record will be digitally protected.


Zydus Cadila receives final approval for Apremilast
Drug Approval | September 24, 2021

Zydus Cadila receives final approval for Apremilast

Zydus' Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy


Indian Pharma Market growth stable in August 2021
News | September 23, 2021

Indian Pharma Market growth stable in August 2021

Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports


AstraZeneca to set up API facility in Ireland at an investment of US $ 360 million
Supply Chain | September 21, 2021

AstraZeneca to set up API facility in Ireland at an investment of US $ 360 million

The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes


Zydus agrees to sell Mifegest and Cytolog to Integrace
News | September 21, 2021

Zydus agrees to sell Mifegest and Cytolog to Integrace

The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.


AYUSH minister Sonowal exhorts researchers to explore Indian traditional medicine
Policy | September 21, 2021

AYUSH minister Sonowal exhorts researchers to explore Indian traditional medicine

Assam is home to more than 1,700 species of medicinal plants


Imfinzi plus chemotherapy tripled patient survival at 3 years
Biotech | September 20, 2021

Imfinzi plus chemotherapy tripled patient survival at 3 years

The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting


Zydus Cadila receives final nod for anti-depressant
Drug Approval | September 18, 2021

Zydus Cadila receives final nod for anti-depressant

The medicine helps restore the balance of certain natural substances (serotonin) in the brain


Pharma exports for August 2021 at Rs 14,871 crores
News | September 17, 2021

Pharma exports for August 2021 at Rs 14,871 crores

In the period April to August 2021, exports stood at Rs 73,469.29 crores compared to Rs 72,275.22 crores for the period April to August 2020 a growth of 1.65 per cent


Biocon Biologics to offer Serum Institute of Life Sciences 15 pc stake at US $ 4.9 billion valuation
Biotech | September 17, 2021

Biocon Biologics to offer Serum Institute of Life Sciences 15 pc stake at US $ 4.9 billion valuation

BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets